Welcome to BioReagent Hub Hotline:19920083827
产品资料来源于品牌方官网 yeasen.com  |  仅供选型参考,规格与库存以官方最新信息为准
品官方资料 · 来源可溯查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-60145ES
10× TBST缓冲液 10× TBST缓冲液
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

10× TBST缓冲液

Scan for product
蛋白研究免疫检测
Product no.60145ES Sizes2 options Documents1 files SourceYeasen · Official
Cat. No. 60145ES76
现货 ¥68.00 促¥95.00
Qty 1
Enquire now
Enquire / bulk Data sheet Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
60145ES76 500 mL ¥68.00促¥95.00 现货 Enquire
60145ES80 2× 500 mL ¥128.00促¥175.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No60145ES
Specification本TBST (10X)配制成TBSTw(1X)后,宜4℃保存,并在一个月内用完。如果室温保存,宜在一周内用完。
Origin翌圣生物科技(上海)股份有限公司
应用方法 蛋白研究用于Western blot等实验中的缓冲液配制和洗涤 免疫检测用于免疫染色实验的缓冲体系
生物特性参数 试剂类别缓冲液 应用免疫印迹、免疫荧光、免疫组化、免疫细胞化学 稀释说明用蒸馏水或去离子水稀释为1X后使用
技术参数 浓度10X浓缩液,使用前稀释为1X pH值7.5±0.1 (25℃) 储存条件4℃保存,一年有效;-20℃长期保存;室温保存一个月内有效 运输条件室温运输 成分250 mM Tris 1500 mM NaCl 0.5% Tween-20
实验类型 免疫印迹用于封闭液制备、抗体稀释及孵育后洗涤 免疫荧光用于封闭液制备、抗体稀释及孵育后洗涤 免疫组化用于封闭液制备、抗体稀释及孵育后洗涤 免疫细胞化学用于封闭液制备、抗体稀释及孵育后洗涤

FAQ

Q:吐温的含量是多少?

A:0.5%的tween-20,体积比。

Documents & Citations

Published citations

[1] Zhang Y, Xia Q, Li Y, et al. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin. Theranostics. 2019;9(1):48-64. Published 2019 Jan 1. doi:10.7150/thno.29715(IF:8.063)

[2] Li S, Ding J, Wang Y, Wang X, Lv L. CD155/TIGIT signaling regulates the effector function of tumor-infiltrating CD8+ T cell by NF-κB pathway in colorectal cancer. J Gastroenterol Hepatol. 2022;37(1):154-163. doi:10.1111/jgh.15730(IF:4.029)

[3] Li Y, Qin G, Du J, Yue P, Zhang Y, Hou N. circRNA LDLRAD3 Enhances the Malignant Behaviors of NSCLC Cells via the miR-20a-5p-SLC7A5 Axis Activating the mTORC1 Signaling Pathway. J Healthc Eng. 2022;2022:2373580. Published 2022 Jan 6. doi:10.1155/2022/2373580(IF:2.682)

Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top